A cheaper, more sustainable way to manufacture breakthrough HIV drug Lenacapavir
|
A novel class of HIV antiretroviral drug,
Lenacapavir offers long-acting protection against HIV transmission.
The study, published in the Journal ... |
Updates & Legacy — Stigmabase is a Canadian Non-Governmental & Nonprofit Initiative. Our mission is to inform about stigma around the world and make the data collected accessible for researchers. Stigmabase is very attentive to misinformation and lists only reliable sources. — The marginalization of individuals or categories of individuals is a too common phenomenon. Millions of people are facing this problem around the world and many complex factors are involved.